MX3244E - Procedimiento mejorado para obtener una composicion efervescente de aspirina - Google Patents

Procedimiento mejorado para obtener una composicion efervescente de aspirina

Info

Publication number
MX3244E
MX3244E MX000545U MX54570U MX3244E MX 3244 E MX3244 E MX 3244E MX 000545 U MX000545 U MX 000545U MX 54570 U MX54570 U MX 54570U MX 3244 E MX3244 E MX 3244E
Authority
MX
Mexico
Prior art keywords
aspirin
suspension
coating material
aqueous solution
surrounded
Prior art date
Application number
MX000545U
Other languages
English (en)
Spanish (es)
Inventor
Graham Arthur Boncey
Maurice John Hedge
James Rae Henderson
Original Assignee
Aspro Nicholas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aspro Nicholas Ltd filed Critical Aspro Nicholas Ltd
Publication of MX3244E publication Critical patent/MX3244E/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX000545U 1969-11-28 1970-11-27 Procedimiento mejorado para obtener una composicion efervescente de aspirina MX3244E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58203/69A GB1287475A (en) 1969-11-28 1969-11-28 Aspirin formulations

Publications (1)

Publication Number Publication Date
MX3244E true MX3244E (es) 1980-08-06

Family

ID=10481023

Family Applications (1)

Application Number Title Priority Date Filing Date
MX000545U MX3244E (es) 1969-11-28 1970-11-27 Procedimiento mejorado para obtener una composicion efervescente de aspirina

Country Status (19)

Country Link
US (1) US3882228A (enExample)
JP (1) JPS516727B1 (enExample)
AT (1) AT302533B (enExample)
BE (1) BE759520A (enExample)
CA (1) CA948108A (enExample)
DE (1) DE2058434C3 (enExample)
DK (1) DK130453B (enExample)
ES (1) ES385974A1 (enExample)
FR (1) FR2073431B1 (enExample)
GB (1) GB1287475A (enExample)
IE (1) IE34756B1 (enExample)
IL (1) IL35714A (enExample)
IN (1) IN129401B (enExample)
MX (1) MX3244E (enExample)
NL (1) NL165928C (enExample)
OA (1) OA03600A (enExample)
SE (1) SE383099B (enExample)
ZA (1) ZA707915B (enExample)
ZM (1) ZM13470A1 (enExample)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636152C2 (de) * 1976-08-11 1980-11-06 Arcana Chem.-Pharm. Fabrik Gmbh, Spittal, Drau (Oesterreich) Verfahren zur Herstellung von Dragees
JPS5364921A (en) * 1976-11-24 1978-06-09 Yasumi Aoki Method of sliding snowfall on metal roof
JPS5373831A (en) * 1976-12-11 1978-06-30 Keiichi Abe Snow sliding roof
US4251518A (en) * 1979-07-03 1981-02-17 Ralston Purina Company Method of preparing readily disintegrable pharmaceutical compositions
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS58110745A (ja) * 1981-12-22 1983-07-01 株式会社西部技研 屋根の積雪防止装置
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
US4548806A (en) * 1982-07-23 1985-10-22 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4459280A (en) * 1982-07-23 1984-07-10 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
JPS6152012U (enExample) * 1984-09-12 1986-04-08
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
GB8525348D0 (en) * 1985-10-15 1985-11-20 Nicholas Kiwi Pacific Pty Ltd Effervescent tablets
US5238686A (en) * 1986-03-27 1993-08-24 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
US5085852A (en) * 1991-04-19 1992-02-04 The Procter & Gamble Company Antimicrobial oral compositions
DE69220317T2 (de) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
FR2708853A1 (fr) * 1993-06-30 1995-02-17 Salsarulo Gilles Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.
DE19606151C2 (de) 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
EP0913178A1 (en) * 1997-11-03 1999-05-06 Boehringer Mannheim Gmbh Process for the manufacture of dry, amorphous products comprising biologically active material by means of convection drying and products obtainable by the process
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6555141B1 (en) 1998-02-27 2003-04-29 Nutramax Laboratories, Inc. L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6941948B2 (en) * 2002-03-07 2005-09-13 Vectura Drug Delivery Medicament storage and delivery devices
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
AU2005201455A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
EP1888032A2 (en) * 2005-05-09 2008-02-20 Foamix Ltd. Saccharide foamable compositions
MX2008001063A (es) 2005-07-22 2008-03-19 Procter & Gamble Composiciones para reducir la incidencia de arritmia inducida por farmacos.
EP1757274B1 (de) * 2005-08-08 2012-07-25 Stada Arzneimittel Ag Brausezubereitung gegen Erkältungssymptome
PL2037758T3 (pl) * 2006-07-12 2019-04-30 Purac Biochem Bv Cząstki klasy spożywczej powlekane częściowo zobojętnionym kwasem
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
AU2009343755B2 (en) 2009-04-01 2013-05-09 Colgate-Palolive Company Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011143347A2 (en) * 2010-05-11 2011-11-17 Sensient Colors Llc Film coating composition and methods of making and using the same
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
MX369634B (es) * 2015-02-20 2019-11-14 Cytec Ind Inc Composiciones de dialquil sulfosuccinato, metodos para hacerlas y metodos de uso.
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
AU2021276611A1 (en) 2020-05-18 2022-12-15 Orexo Ab New pharmaceutical composition for drug delivery
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
TW202333658A (zh) 2021-11-25 2023-09-01 瑞典商奥瑞克索股份公司 包含腎上腺素之新穎醫藥組合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299504A (fr) * 1959-04-15 1962-07-27 Philips Nv Procédé de préparation de produits secs pour poudrage, stables à l'air, contenant en particulier des substances douées d'activité biologique
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
US3293132A (en) * 1963-03-25 1966-12-20 Merck & Co Inc Spray dried vitamin compositions and method of preparation
NL6414091A (nl) * 1964-12-04 1966-06-06 Organon Nv Werkwijze voor het vloeibaar maken van poeders alsmede de aldus verkregen poeders
US3384546A (en) * 1965-05-28 1968-05-21 Miles Lab Directly compressed low-density crystalline sorbitol pharmaceutical tablets

Also Published As

Publication number Publication date
NL165928C (nl) 1981-06-15
IL35714A (en) 1974-03-14
IL35714A0 (en) 1971-01-28
ZA707915B (en) 1971-08-25
SE383099B (sv) 1976-03-01
IE34756B1 (en) 1975-08-06
DE2058434A1 (de) 1971-06-03
ZM13470A1 (en) 1971-11-22
FR2073431A1 (enExample) 1971-10-01
DE2058434B2 (de) 1980-04-24
OA03600A (fr) 1971-03-30
FR2073431B1 (enExample) 1974-03-22
DK130453B (da) 1975-02-24
US3882228A (en) 1975-05-06
DE2058434C3 (de) 1980-12-18
JPS516727B1 (enExample) 1976-03-02
BE759520A (fr) 1971-04-30
NL7017417A (enExample) 1971-06-02
NL165928B (nl) 1981-01-15
GB1287475A (en) 1972-08-31
AT302533B (de) 1972-10-25
DK130453C (enExample) 1975-07-21
ES385974A1 (es) 1973-05-01
IE34756L (en) 1971-05-28
IN129401B (enExample) 1975-08-16
CA948108A (en) 1974-05-28

Similar Documents

Publication Publication Date Title
MX3244E (es) Procedimiento mejorado para obtener una composicion efervescente de aspirina
PT64770A (fr) Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-difenilicos
SE426500B (sv) Beleggningskomposition av fluorpolymer innehallande alkalimetallsilikat och ett salt av polyamidsyra, samt anvendning av kompositionen
PT64771A (fr) Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-nitro-difenilicos
CH502436A (fr) Composition détachante destinée à être distribuée sous forme d'aérosol
CH521979A (fr) Procédé pour la préparation d'hexahydro-imidazoquinoléines substituées
CH529797A (it) Procedimento per la preparazione dei polimeri dell'etilene
SE396010B (sv) Forfarande for framstellning av aktiva emnen innehallande preparat med langvarig verkan i form av tabletter, drageer eller kapslar
IT1035011B (it) Procedimento per la preparazione dell acido 7 amminocefalosporaico e dei suoi derivati
BE801273Q (fr) Composition sous forme d'aerosol utilisee pour combattre la transpiration
DK135285B (da) Analogifremgangsmåde til fremstilling af 5-substituerede 5,10-dihydro-11H-dibenzo(b,e)(1,4)diazepin-11-oner eller 11-substituerede 5, 11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner eller syreadditionssalte deraf.
IL51465A0 (en) The preparation of 2,2-dimethyl-3-(2',2'-dichlorovinyl)-cyclopropane-1-carboxylic acid
FI47183C (fi) Menetelmä puhtaan digoksiini-3'''-monometyylieetterin valmistamiseksi.
JPS51144453A (en) Preparation of polyamide resin chips
SE382226B (sv) Forfarande for framstellning av en amylosprodukt innehallande minst 50 vikt- % naturlig amylos.
SE389669B (sv) Forfarande for framstellning av 15-metyl eller 15-etyl-prostaglandinforeningar av typ pge
IT1033037B (it) Procedimento per la preparazione di 2 amminobenzofenoni n mono so stituiti
JPS51119752A (en) Silicon emulsion compositions
GB472138A (en) Improvements in or relating to the manufacture of lecithin preparations
FR1520608A (fr) Dispositif pour l'arrêt du remplissage des moules, notamment des moules servant à la réalisation des semelles de chaussures
SE398878B (sv) Forfarande for framstellning av substituerade 2,4-diamino-5-bensylpyrimidiner
BE750263A (fr) Procede pour la preparation d'amino-cetones
JPS51124099A (en) Fire fighting medicine
BE767166A (fr) Procede pour la preparation d'epichlorhydrine pure
CH548973A (it) Metodo per la preparazione degli (alpha)-monogliceridi dell' acido benzoico.